Document Detail


Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
MedLine Citation:
PMID:  20306693     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To measure sCD44 and its expression in ALL children before and after induction of remission (day 28) and their relation to prognostic factors. Newly diagnosed 30 ALL pediatric patients were examined for sCD44 by ELISA and CD44 expression by flowcytometry and their levels after induction of remission. We correlated them to age, sex, TLC, Hb, platelet count, blast % in PB and BM, Immunophenotyping, and LDH. CD44 expression in ALL patients at the time of diagnosis ranged from 0 - 98% with a mean +/- SD of (41.23 +/- 23.99) and in the control group (range 0 - 11 with a mean +/- SD of 5.5 +/- 6.58), the % of expression was significantly higher in ALL patients than control group (P = 0.001). CD44 expression was significantly decreased by induction of remission (P = 0.001). sCD44 concentration in ALL patients at the time of diagnosis ranged from 105- 449 ng/dl with a mean +/- SD of (246.5 +/- 99.51) and in the control group (range 103 -243 ng/dl with a mean +/- SD of 160.65 +/- 37.12), sCD44 was significantly higher in ALL patients than control group (P = 0.001). sCD44 was significantly decreased after induction of remission (P = 0.001). LDH was elevated in the patients group than the control, (P = 0.001). In conclusion, LDH level at time of ALL diagnosis is an important risk determinant and correlate with degree of anemia, high TLC and high PB absolute blast count. High sCD44 level at the time of diagnosis and rapid decline in its level after treatment suggesting that sCD44 may be a good marker for prognosis and a marker for monitoring response to therapy, a second elevation of sCD44 level after its decline by therapy may suggest ALL relapse. Elevated CD44 expression in ALL patients may mediate lymphoblast metastatic migration.
Authors:
Mohammed Ibrahim Sayed Ahmed; Hoda Mohammed Abo El Fotoh Hassab
Related Documents :
8400243 - Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in ...
11753603 - Clinical importance of interphase cytogenetics detecting occult chromosome lesions in m...
8287743 - Histologic and microbiologic features of biopsy samples from patients with normal and i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Egyptian journal of immunology / Egyptian Association of Immunologists     Volume:  15     ISSN:  1110-4902     ISO Abbreviation:  Egypt J Immunol     Publication Date:  2008  
Date Detail:
Created Date:  2010-03-23     Completed Date:  2010-04-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9816016     Medline TA:  Egypt J Immunol     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  101-11     Citation Subset:  IM    
Affiliation:
Department of Clinical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD44 / biosynthesis,  blood*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Child
Child, Preschool
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
Humans
Immunophenotyping
Infant
Leukocytes, Mononuclear / immunology,  metabolism*
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood*,  diagnosis,  drug therapy
Prognosis
Remission Induction
Solubility
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antigens, CD44

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New mutations in C1 esterase inhibitor (SERPING1) in a German family with hereditary angioedema.
Next Document:  Role of Foxp3 and regulatory CD4+CD25+ T-lymphocytes in bronchial asthma.